UnknownNot Applicable

Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis

Spain76 participantsStarted 2021-02-15

Plain-language summary

The objective of this study is to evaluate the efficacy of the consumption of the one probiotic strain in the prevention of new vaginal candidiasis events in women with recurrent vaginal candidiasis. This is a preliminary study whose purpose is to know if this probiotic is effective in reducing the number of candidiasis events and / or increasing the time between possible relapses in women diagnosed with RVVC.

Who can participate

Age range18 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy women from 18 to 49 years old.
✓. Having suffered at least four outbreaks of vaginal yeast infection in the last year.
✓. Signed Informed Consent Form.
✓. Agree to provide the scheduled samples.
✓. Agree to perform gynecological examinations
✓. Agree to report candidiasis events that occur during the study.
✓. Ability to complete surveys.

Exclusion criteria

✕. Being currently consuming or having consumed a probiotic in the two weeks prior to the study.
✕. Being under antibiotic treatment at the time of beginning the study.
✕. Being under pharmacological treatment for the treatment of candidiasis.
✕. Have an allergy to an antibiotic

What they're measuring

Recurrence of candidiasis events

Timeframe: 6 months

Time between episodes

Timeframe: 6 months

Trial details

NCT IDNCT04639544

SponsorBiosearch S.A.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-08-31

Contact for this trial

Jose Maldonado Lobón, PhD

+34 616556789 jamaldonado@biosearchlife.com

View on ClinicalTrials.gov More Recurrent Vulvovaginal Candidiasis trials